Home / Companies / Teva Pharmaceutical Industries Limited / 28 May 2026
Teva Pharmaceutical Industries Limited: meeting of 28 May 2026
Votes reported on Form N-PX, item by item
742 Form N-PX filers reported votes at the Teva Pharmaceutical Industries Limited meeting of 28 May 2026. Their records fall into 4 items below, in ballot order: management items first, then proposals from security holders. Each bar shows how the reporting filers split; it is not the result of the meeting.
foragainstabstain, withhold or otheramber tick: the portion cast against management
Items
DIRECTOR ELECTIONSIssuer
Director elections
1 nominee; 92.9% of reported votes for; 11 filers withheld from or voted against at least one nominee.
311 vote records from 166 filers. 8 of the 166 filers that marked the item either way voted against management.
SECTION 14A SAY-ON-PAY VOTESIssuer
Advisory vote on executive pay (say-on-pay)
1,007 vote records from 737 filers. 30 of the 708 filers that marked the item either way voted against management. 29 filers reported this item without a management mark.
AUDIT-RELATEDIssuer
Audit-related items (auditor ratification)
308 vote records from 164 filers. 8 of the 164 filers that marked the item either way voted against management.
Several categoriesSecurity holder
Shareholder proposals (not separable from the filings)
Filers described these proposals in wordings that could not be matched to one another, so they are shown together.
4 vote records from 2 filers. 0 of the 2 filers that marked the item either way voted against management.
How the largest families voted
* against management. A family's position is the way most of its reported shares were voted across its filers; "split" means no single position led. "No report" means none of the family's filers listed the item.
Questions
How did large funds vote at the Teva Pharmaceutical Industries Limited meeting?
742 Form N-PX filers reported votes at the meeting of 28 May 2026. On say-on-pay, 30 of 708 voted against management (4.2%). The family table lists each of the largest families item by item.
Is this the meeting result?
No. These are the votes of funds and managers that file Form N-PX, counted by filer and by the shares they reported. The certified result, which includes every shareholder, is reported by Teva Pharmaceutical Industries Limited on Form 8-K.
Why are director elections shown as counts only?
Director records name the nominee. This site does not publish pages or rows about individuals, so for director elections it keeps the number of nominees and the split of votes and discards the wording.
Every meeting on file for Teva Pharmaceutical Industries Limited
Provenance: SEC EDGAR, Form N-PX and N-PX/A filings listing Teva Pharmaceutical Industries Limited with a meeting date within three days of 28 May 2026. Proposal titles are the most common wording among filers and are replaced by the SEC category where a wording could name a person. Not verified by the SEC. Filings read through 23 Sep 2026.